IBDEI01Z ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,414,1,2,0)
 ;;=2^295.50
 ;;^UTILITY(U,$J,358.3,414,1,5,0)
 ;;=5^Latent Schizophrenia NOS
 ;;^UTILITY(U,$J,358.3,414,2)
 ;;=^68517
 ;;^UTILITY(U,$J,358.3,415,0)
 ;;=295.60^^3^40^22
 ;;^UTILITY(U,$J,358.3,415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,415,1,2,0)
 ;;=2^295.60
 ;;^UTILITY(U,$J,358.3,415,1,5,0)
 ;;=5^Undifferentiated Schizophrenia NOS
 ;;^UTILITY(U,$J,358.3,415,2)
 ;;=^331851
 ;;^UTILITY(U,$J,358.3,416,0)
 ;;=295.70^^3^40^10
 ;;^UTILITY(U,$J,358.3,416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,416,1,2,0)
 ;;=2^295.70
 ;;^UTILITY(U,$J,358.3,416,1,5,0)
 ;;=5^Schizoaffective Disorder NOS
 ;;^UTILITY(U,$J,358.3,416,2)
 ;;=^331857
 ;;^UTILITY(U,$J,358.3,417,0)
 ;;=295.90^^3^40^13
 ;;^UTILITY(U,$J,358.3,417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,417,1,2,0)
 ;;=2^295.90
 ;;^UTILITY(U,$J,358.3,417,1,5,0)
 ;;=5^Schizophrenia NOS,Unspec
 ;;^UTILITY(U,$J,358.3,417,2)
 ;;=^108287
 ;;^UTILITY(U,$J,358.3,418,0)
 ;;=300.11^^3^41^1
 ;;^UTILITY(U,$J,358.3,418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,418,1,2,0)
 ;;=2^300.11
 ;;^UTILITY(U,$J,358.3,418,1,5,0)
 ;;=5^Conversion Disorder
 ;;^UTILITY(U,$J,358.3,418,2)
 ;;=^28139
 ;;^UTILITY(U,$J,358.3,419,0)
 ;;=300.7^^3^41^2
 ;;^UTILITY(U,$J,358.3,419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,419,1,2,0)
 ;;=2^300.7
 ;;^UTILITY(U,$J,358.3,419,1,5,0)
 ;;=5^Hyponchondriasis
 ;;^UTILITY(U,$J,358.3,419,2)
 ;;=^60556
 ;;^UTILITY(U,$J,358.3,420,0)
 ;;=300.81^^3^41^3
 ;;^UTILITY(U,$J,358.3,420,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,420,1,2,0)
 ;;=2^300.81
 ;;^UTILITY(U,$J,358.3,420,1,5,0)
 ;;=5^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,420,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,421,0)
 ;;=307.1^^3^42^1
 ;;^UTILITY(U,$J,358.3,421,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,421,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,421,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,421,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,422,0)
 ;;=307.51^^3^42^2
 ;;^UTILITY(U,$J,358.3,422,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,422,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,422,1,5,0)
 ;;=5^Bulemia
 ;;^UTILITY(U,$J,358.3,422,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,423,0)
 ;;=307.50^^3^42^3
 ;;^UTILITY(U,$J,358.3,423,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,423,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,423,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,423,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,424,0)
 ;;=333.99^^3^43^1
 ;;^UTILITY(U,$J,358.3,424,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,424,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,424,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,424,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,425,0)
 ;;=332.0^^3^43^3
 ;;^UTILITY(U,$J,358.3,425,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,425,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,425,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,425,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,426,0)
 ;;=333.79^^3^43^2
 ;;^UTILITY(U,$J,358.3,426,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,426,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,426,1,5,0)
 ;;=5^Acute Dystonia
 ;;^UTILITY(U,$J,358.3,426,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,427,0)
 ;;=333.85^^3^43^4
 ;;^UTILITY(U,$J,358.3,427,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,427,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,427,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,427,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,428,0)
 ;;=V87.39^^3^44^1
 ;;^UTILITY(U,$J,358.3,428,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,428,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,428,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,428,2)
 ;;=^336815
